The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Hypoxia-inducible factor 2α regulates macrophage function in mouse models of acute and tumor inflammation
Open accessAbstract
Hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha display unique and sometimes opposing activities in regulating cellular energy homeostasis, cell fate decisions, and oncogenesis. Macrophages exposed to hypoxia accumulate both HIF-1alpha and HIF-2alpha, and overexpression of HIF-2alpha in tumor-associated macrophages (TAMs) is specifically correlated with high-grade human tumors and poor prognosis. However, the precise role of HIF-2alpha during macrophage-mediated inflammatory responses remains unclear. To fully characterize cellular hypoxic adaptations, distinct functions of HIF-1alpha versus HIF-2alpha must be elucidated. We demonstrate here that mice lacking HIF-2alpha in myeloid cells (Hif2aDelta/Delta mice) are resistant to lipopolysaccharide-induced endotoxemia and display a marked inability to mount inflammatory responses to cutaneous and peritoneal irritants. Furthermore, HIF-2alpha directly regulated proinflammatory cytokine/chemokine expression in macrophages activated in vitro. Hif2aDelta/Delta mice displayed reduced TAM infiltration in independent murine hepatocellular and colitis-associated colon carcinoma models, and this was associated with reduced tumor cell proliferation and progression. Notably, HIF-2alpha modulated macrophage migration by regulating the expression of the cytokine receptor M-CSFR and the chemokine receptor CXCR4, without altering intracellular ATP levels. Collectively, our data identify HIF-2alpha as an important regulator of innate immunity, suggesting it may be a useful therapeutic target for treating inflammatory disorders and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Myeloid-specific HIF-1α deletion results in defective glycolysis and ATP generation, leading to impairment of myeloid cell motility and function (Fig. 2B) [61,62].”
From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both HIF-1α or HIF-2α expression in TAMs have been associated with tumor progression and/or poor prognosis in multiple tumor types, whereas lack of HIF-1α or HIF-2α in TAMs decreases metastasis, cell proliferation, and expression of pro-inflammatory cytokines such as IL-6 [73–76].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [76]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both HIF-1α or HIF-2α expression in TAMs have been associated with tumor progression and/or poor prognosis in multiple tumor types, whereas lack of HIF-1α or HIF-2α in TAMs decreases metastasis, cell proliferation, and expression of pro-inflammatory cytokines such as IL-6 [73–76].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [76]
Experimental — accuracy not yet measuredIn the citing paper
“Indeed, TAM presence and number has been directly correlated with prognosis in a number of cancer types and model systems [42–44].”
From Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine (2012) · cites this paper as [42]
In the citing paper
“HIF2α is required for cytokine induction in macrophages (Imtiyaz et al., 2010).”
From Iron Regulatory Proteins Mediate Host Resistance to Salmonella Infection (2015) · cites this paper as Imtiyaz et al., 2010
In the citing paper
“Hif-2α is an important transcriptional regulator of hypoxic responses, controlling a variety of processes including hypoxic regulation of EPO synthesis [48, 49] and macrophage function [50, 51].”
From Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function (2013) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1256 · Cited by 3,413
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251
Activators and Target Genes of Rel/NF-кB Transcription Factors
Loop, T., & Pahl, H. L. (2003) · Springer eBooks · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,179
Lutz, M. B., Kukutsch, N. A., Ogilvie, A. L. J., Rößner, S., Koch, F., Romani, N., & Schuler, G. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00204-x · Cited by 2,972
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000) · Nature · doi:10.1038/35004599 · Cited by 2,617
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., & Cerami, A. (1987) · Nature · doi:10.1038/330662a0 · Cited by 2,448
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Flagged first, then by citations
Research works printed but not linked: 2
- Raick, 1973, Cancer Res., 33, 269
- Leek, 2002, Cancer Res., 62, 1326
Cited by
Sorted by citations
Items 201–300 of 461
Jeelani, I., Moon, J.-S., da Cunha, F. F., Nasamran, C. A., Jeon, S., Zhang, X., Bandyopadhyay, G. K., Dobaczewska, K., Mikulski, Z., Hosseini, M., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0284 · Cited by 50
A Window of Opportunity: Targeting Cancer Endothelium to Enhance Immunotherapy
Duru, G., van Egmond, M., & Heemskerk, N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.584723 · Cited by 44
Netrin-1: A Modulator of Macrophage Driven Acute and Chronic Inflammation
Ziegon, L., & Schlegel, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010275 · Cited by 48
Hypoxia-inducible factor as a bridge between healthy barrier function, wound healing, and fibrosis
Steiner, C. A., Cartwright, I. M., Taylor, C. T., & Colgan, S. P. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00227.2022 · Cited by 44
Izquierdo, H. M., Brandi, P., Gómez, M. J., Conde‐Garrosa, R., Priego, E., Enamorado, M., Martínez-Cano, S., Sánchez, I. B., Conejero, L., Jiménez‐Carretero, D., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.034 · Cited by 42
Disease Resolution in Chikungunya—What Decides the Outcome?
Srivastava, P., Kumar, A., Hasan, A., Mehta, D., Kumar, R., Sharma, C., & Sunil, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00695 · Cited by 44
Unlocking mammalian regeneration through hypoxia inducible factor one alpha signaling
DeFrates, K. G., Franco, D., Heber‐Katz, E., & Messersmith, P. B. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120646 · Cited by 43
Richter, S., Qin, N., Pacak, K., & Eisenhofer, G. (2013) · Advances in Pharmacology · doi:10.1016/b978-0-12-411512-5.00014-2 · Cited by 42
The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation
Acuña-Pilarte, K., & Koh, M. Y. (2025) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2025.06.005 · Cited by 64
Wang, N., Luo, H., Yin, G., Dong, C.-R., Xu, M., Chen, G. Y., & Liu, Z. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/589423 · Cited by 41
Brown, E., Rowan, C. R., Strowitzki, M. J., Fagundes, R. R., Faber, K. N., Güntsch, A., Halligan, D. N., Kugler, J., Jones, F., Lee, C. T., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902103r · Cited by 43
Wei, Y., Chen, J., Cai, G., Lu, W., Xu, W., Wang, R., Lin, Y., & Yang, C. (2020) · Inflammation · doi:10.1007/s10753-020-01314-w · Cited by 41
Myeloid HIF-1 Is Protective in Helicobacter pylori–Mediated Gastritis
Matak, P., Heinis, M., Mathieu, J. R. R., Corriden, R., Cuvellier, S., Delga, S., Mounier, R., Rouquette, A., Raymond, J., Lamarque, D., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401260 · Cited by 39
Bae, W., Shin, M., Kang, S., Zhang, J., Kim, J., Lee, S.-I., & Kim, E. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25078 · Cited by 40
Glioprotective Effect of Resveratrol: an Emerging Therapeutic Role for Oligodendroglial Cells
da Rosa, P. M., Martins, L. A. M., Souza, D. O., & Quincozes‐Santos, A. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0510-x · Cited by 40
Perspectives on Hypoxia Signaling in Tumor Stroma
Zhang, Y., Coleman, M., & Brekken, R. A. (2021) · Cancers · doi:10.3390/cancers13123070 · Cited by 39
Wiese, M., Gerlach, R. G., Popp, I., Matuszak, J., Mahapatro, M., Castiglione, K., Chakravortty, D., Willam, C., Hensel, M., Bogdan, C., et al. (2012) · Infection and Immunity · doi:10.1128/iai.05972-11 · Cited by 39
T-2 toxin enhances catabolic activity of hypertrophic chondrocytes through ROS-NF-κB-HIF-2α pathway
Tian, J., Yan, J., Wang, W., Zhong, N., Tian, L., Sun, J., Min, Z., Ma, J., & Lu, S. (2012) · Toxicology in Vitro · doi:10.1016/j.tiv.2012.07.002 · Cited by 39
Inverse Correlation between IL-10 and HIF-1α in Macrophages Infected with Histoplasma capsulatum
Fecher, R. A., Horwath, M. C., Friedrich, D., Rupp, J., & Deepe, G. S. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600342 · Cited by 38
Tausendschön, M., Rehli, M., Dehne, N., Schmidl, C., Döring, C., Hansmann, M.-L., & Brüne, B. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.10.006 · Cited by 43
Mohammadinejad, F., Mohammadabadi, M., Roudbari, Z., & Sadkowski, T. (2022) · Animals · doi:10.3390/ani12243471 · Cited by 39
Progression of m6A in the tumor microenvironment: hypoxia, immune and metabolic reprogramming
Han, X., Zhu, Y., Ke, J., Zhai, Y., Huang, M., Zhang, X., He, H., Zhang, X., Zhao, X., Guo, K., et al. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02092-2 · Cited by 40
Crosstalk between oxygen- and nitric oxide-dependent signaling pathways in angiogenesis
Fraisl, P. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.02.010 · Cited by 36
Macías, D., Moore, S., Crosby, A., Southwood, M. R., Du, X., Tan, H., Xie, S., Vassallo, A. M., Wood, A. J. T., Wallace, E. M., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.02061-2019 · Cited by 35
Baradaran, A., Asadzadeh, Z., Hemmat, N., Baghbanzadeh, A., Shadbad, M. A., Khosravi, N., Derakhshani, A., Alemohammad, H., Nour, M. A., Safarpour, H., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112588 · Cited by 37
RetractedDeBerge, M., Zhang, S., Glinton, K. E., Grigoryeva, L., Hussein, I., Vorovich, E., Ho, K. J., Luo, X., & Thorp, E. B. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01428 · Cited by 40
Weinkopff, T., Roys, H., Bowlin, A. K., & Scott, P. (2019) · Infection and Immunity · doi:10.1128/iai.00088-19 · Cited by 36
Song, C. W., Kim, H., Cho, H., Kim, M., Paek, S.-H., Park, H. J., Griffin, R. J., Terezakis, S. A., & Cho, L. C. (2022) · Cancers · doi:10.3390/cancers14133273 · Cited by 35
The Regulatory Network of Transcription Factors in Macrophage Polarization
Liu, J., Wang, M., & Zhao, Y. X. (2025) · ImmunoTargets and Therapy · doi:10.2147/itt.s494550 · Cited by 38
Mignogna, C., Signorelli, F., Vismara, M. F. M., Zeppa, P., Camastra, C., Barni, T., Donato, G., & Vito, A. D. (2016) · Pathology - Research and Practice · doi:10.1016/j.prp.2016.02.020 · Cited by 35
Study on hypoxia-inducible factor and its roles in immune system
Kiani, A. A., Elyasi, H., Ghoreyshi, S., Nouri, N., Safarzadeh, A., & Nafari, A. (2021) · Immunological Medicine · doi:10.1080/25785826.2021.1910187 · Cited by 38
Pericytes contribute to pulmonary vascular remodeling via HIF2α signaling
Kim, H., Liu, Y., Kim, J. J., Kim, Y., Klouda, T. M., Fisch, S., Baek, S. H., Liu, T., Dahlberg, S. E., Hu, C., et al. (2024) · EMBO Reports · doi:10.1038/s44319-023-00054-w · Cited by 35
Role of Circadian Transcription Factor Rev-Erb in Metabolism and Tissue Fibrosis
Raza, G. S., Sodum, N., Kaya, Y., & Herzig, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112954 · Cited by 35
Wang, W., Li, X., Zheng, D., Zhang, D., Huang, S., Zhang, X., Ai, F., Wang, X., Ma, J., Xiong, W., et al. (2013) · Inflammation Research · doi:10.1007/s00011-013-0619-y · Cited by 33
Myeloid Cell Hypoxia-Inducible Factors Promote Resolution of Inflammation in Experimental Colitis
Lin, N., Shay, J. E. S., Xie, H. J., Lee, D. S. M., Skuli, N., Tang, Q., Zhou, Z., Azzam, A., Meng, H., Wang, H., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02565 · Cited by 30
Self-citationHara, T., Mimura, K., Abe, T., Shioi, G., Seiki, M., & Sakamoto, T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.271726 · Cited by 32
Pulmonary Arterial Hypertension: Iron Matters
Ramakrishnan, L., Pedersen, S. L., Toe, Q. K., Quinlan, G. J., & Wort, S. J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00641 · Cited by 31
Hypoxia-Induced Signaling in Gut and Liver Pathobiology
Solanki, S. A., & Shah, Y. M. (2023) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-051122-094743 · Cited by 34
Data Driven Mathematical Model of Colon Cancer Progression
Kirshtein, A., Akbarinejad, S., Hao, W., Le, T., Su, S., Aronow, R. A., & Shahriyari, L. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123947 · Cited by 29
Dehn, S., DeBerge, M., Yeap, X., Yvan‐Charvet, L., Fang, D., Eltzschig, H. K., Miller, S. D., & Thorp, E. B. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600402 · Cited by 31
Decreased lymphatic HIF-2α accentuates lymphatic remodeling in lymphedema
Jiang, X., Tian, W., Granucci, E. J., Tu, A. B., Kim, D., Dahms, P. A., Pasupneti, S., Peng, G., Kim, Y., Lim, A. H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136164 · Cited by 28
Anti-Cancer Activity of Phytochemicals Targeting Hypoxia-Inducible Factor-1 Alpha
Yun, B. D., Son, S. W., Choi, S. Y., Kuh, H. J., Oh, T., & Park, J. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189819 · Cited by 31
Xu, Z., Zhao, L., Zhu, L., He, M. Y., Zheng, L., & Wu, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077890 · Cited by 29
Shafqat, A., Omer, M. H., Ahmed, E. N., Mushtaq, A. H., Ijaz, E., Ahmed, Z., AlKattan, K. M., & Yaqinuddin, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1200941 · Cited by 32
Unravelling monocyte functions: from the guardians of health to the regulators of disease
Mildner, A., Kim, K.-W., & Yona, S. (2024) · Discovery Immunology · doi:10.1093/discim/kyae014 · Cited by 35
Multiphysics and multiscale modeling of microthrombosis in COVID-19
Li, H., Deng, Y., Li, Z., Dorken‐Gallastegi, A., Mantzoros, C. S., Frydman, G. H., & Karniadakis, G. E. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009892 · Cited by 27
Macrophage NOS2 in Tumor Leukocytes
Brüne, B., Courtial, N., Dehne, N., Syed, S. N., & Weigert, A. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6811 · Cited by 28
Myronenko, O., Foris, V., Crnković, S., Olschewski, A., Rocha, S., Nicolls, M. R., & Olschewski, H. (2023) · European Respiratory Review · doi:10.1183/16000617.0173-2022 · Cited by 28
Ting, K. K. Y., Yu, P., Dow, R., Floro, E. J., Ibrahim, H. M., Scipione, C. A., Hyduk, S. J., Polenz, C. K., Zaslaver, O., Karmaus, P. W. F., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300293 · Cited by 27
4T1 Murine Mammary Carcinoma Cells Enhance Macrophage-Mediated Innate Inflammatory Responses
Madera, L., Greenshields, A. L., Coombs, M. R. P., & Hoskin, D. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133385 · Cited by 27
Hypoxia-Independent Gene Expression Mediated by SOX9 Promotes Aggressive Pancreatic Tumor Biology
Čamaj, P., Jäckel, C., Krebs, S., DeToni, E. N., Blum, H., Jauch, K., Nelson, P. J., & Bruns, C. J. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0351 · Cited by 27
HIF2α is a direct regulator of neutrophil motility
Sormendi, S., Deygas, M., Sinha, A. N., Krüger, A., Kourtzelis, I., Lay, G. L., Bernard, M., Sáez, P. J., Gerlach, M., Franke, K., et al. (2021) · Blood · doi:10.1182/blood.2020007505 · Cited by 24
CXC Chemokine Signaling in Progression of Epithelial Ovarian Cancer: Theranostic Perspectives
Huang, X., Hao, J., Tan, Y. Q., Zhu, T., Pandey, V., & Lobie, P. E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052642 · Cited by 26
Inflammatory processes involved in NASH-related hepatocellular carcinoma
Cannito, S., Dianzani, U., Parola, M., Albano, E., & Sutti, S. (2023) · Bioscience Reports · doi:10.1042/bsr20221271 · Cited by 29
Myeloid HIFs Are Dispensable for Resolution of Inflammation during Skeletal Muscle Regeneration
Gondin, J., Théret, M., Duhamel, G., Pegan, K., Mathieu, J. R. R., Peyssonnaux, C., Cuvellier, S., Latroche, C., Chazaud, B., Bendahan, D., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401420 · Cited by 26
Dong, Y., Zhang, S., Gao, X., Yin, D., Wang, T., Li, Z., Wan, Z., Wei, M., Luo, Y., Yang, G., et al. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.02.008 · Cited by 28
Mechanisms controlling bacterial infection in myeloid cells under hypoxic conditions
Hayek, I., Schatz, V., Bogdan, C., Jantsch, J., & Lührmann, A. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03684-8 · Cited by 25
Yang, X., Lei, P., Huang, L., Tang, X., Wei, B., & Wei, H. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.58876 · Cited by 25
The endothelial glycocalyx in critical illness: A pediatric perspective
Richter, R. P., Payne, G. A., Ambalavanan, N., Gaggar, A., & Richter, J. R. (2022) · Matrix Biology Plus · doi:10.1016/j.mbplus.2022.100106 · Cited by 25
Biology of macrophage fate decision: Implication in inflammatory disorders
Yadav, S., Dwivedi, A., & Tripathi, A. (2022) · Cell Biology International · doi:10.1002/cbin.11854 · Cited by 26
Song, S., Zhang, Y., Duan, X., Liu, C., Du, Y., Wang, X., Luo, Y., & Cui, Y. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00551-5 · Cited by 26
Macrophage HIF‐2α regulates tumor‐suppressive Spint1 in the tumor microenvironment
Susen, R. M., Bauer, R., Olesch, C., Fuhrmann, D. C., Fink, A. F., Dehne, N., Jain, A., Ebersberger, I., Schmid, T., & Brüne, B. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.23103 · Cited by 24
Infection by Leishmania amazonensis in mice: A potential model for chronic hypoxia
Araújo, A. P., Arrais-Silva, W. W., & Giorgio, S. (2012) · Acta Histochemica · doi:10.1016/j.acthis.2012.01.007 · Cited by 27
Gharzeddine, K., Prieto, C. G., Malier, M., Hennot, C., Grespan, R., Yamaryo‐Botté, Y., Botté, C. Y., Thomas, F., Laverrière, M., Girard, É., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-009602 · Cited by 28
Crosstalk between lactate and tumor-associated immune cells: clinical relevance and insight
Sun, K., Shen, Y., Xiao, X., Xu, H., Zhang, Q., & Li, M. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1506849 · Cited by 26
Mechanisms of tumor-associated macrophages affecting the progression of hepatocellular carcinoma
Yuan, Y., Wu, D., Li, J., Huang, D., Zhao, Y., Gao, T., Zhuang, Z., Cui, Y., Zheng, D., & Ying, T. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1217400 · Cited by 22
Hypoxia inducible factor 1α: A critical factor for the immune response to pathogens and Leishmania
Charpentier, T., Hammami, A., & Stäger, S. (2016) · Cellular Immunology · doi:10.1016/j.cellimm.2016.06.002 · Cited by 21
Investigating the real role of HIF-1 and HIF-2 in iron recycling by macrophages
Mathieu, J. R. R., Heinis, M., Zumerle, S., Delga, S., Le Bon, A., & Peyssonnaux, C. (2014) · Haematologica · doi:10.3324/haematol.2013.102319 · Cited by 22
Espinoza, F. I., Tankov, S., Chliate, S., Couto, J. P., Marinari, E., Vermeil, T., Lecoultre, M., Harane, N. E., Dutoit, V., Migliorini, D., et al. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05642-8 · Cited by 25
Hypoxia-inducible factors not only regulate but also are myeloid-cell treatment targets
Kling, L., Schreiber, A., Eckardt, K., & Kettritz, R. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.4ri0820-535r · Cited by 25
Mesaros, O., Jimbu, L., Neaga, A., Popescu, C., Berceanu, I., Tomuleasa, C., Fetică, B., & Zdrenghea, M. (2020) · Biomedicines · doi:10.3390/biomedicines8110516 · Cited by 21
Pharmacological ascorbate as a novel therapeutic strategy to enhance cancer immunotherapy
Zaher, A., Stephens, L. M., Miller, A. M., Hartwig, S. M., Stolwijk, J. M., Petronek, M. S., Zacharias, Z. R., Wadas, T. J., Monga, V., Cullen, J. J., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.989000 · Cited by 25
Inflammatory cues acting on the adult intestinal stem cells and the early onset of cancer (Review)
Barbaro, A. D. L., Perletti, G., Bonapace, I. M., & Monti, E. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2490 · Cited by 22
Oishi, K., Sakaguchi, T., Baba, S., Suzuki, S., & Konno, H. (2014) · Surgery Today · doi:10.1007/s00595-014-0989-y · Cited by 22
Barakat, R., & Redzic, Z. B. (2015) · Fluids and Barriers of the CNS · doi:10.1186/s12987-015-0002-1 · Cited by 22
Hypoxia‐Inducible Factor‐2α Signaling in the Skeletal System
Mendoza, S. V., Genetos, D. C., & Yellowley, C. E. (2023) · JBMR Plus · doi:10.1002/jbm4.10733 · Cited by 25
Whyte, M. K. B., & Walmsley, S. R. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201403-108aw · Cited by 22
The tumour microenvironment links complement system dysregulation and hypoxic signalling
Olcina, M. M., Kim, R. K., Melemenidis, S., Graves, E. E., & Giaccia, A. J. (2018) · British Journal of Radiology · doi:10.1259/bjr.20180069 · Cited by 20
Chronic hypoxia impairs skeletal muscle repair via HIF‐2α stabilization
Yin, A., Fu, W., Elengickal, A. J., Kim, J., Liu, Y., Bigot, A., Mamchaoui, K., Call, J. A., & Yin, H. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13436 · Cited by 22
Mu, H., Ge, Y. P., Li, H., Wang, M., Cui, Y., Zhang, T., Song, T., & Liu, C. (2021) · Cellular Oncology · doi:10.1007/s13402-021-00625-w · Cited by 23
Hypoxic State of Cells and Immunosenescence: A Focus on the Role of the HIF Signaling Pathway
Troise, D. E., Infante, B., Mercuri, S., Netti, G. S., Ranieri, E., Gesualdo, L., Stallone, G., & Pontrelli, P. (2023) · Biomedicines · doi:10.3390/biomedicines11082163 · Cited by 22
RNA m6A modifications regulate crosstalk between tumor metabolism and immunity
Gu, J., Cao, H., Chen, X., Zhang, X. D., Thorne, R. F., & Liu, X. (2023) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1829 · Cited by 22
The Janus face of HIF-1α in ischemic stroke and the possible associated pathways
Amin, N., Abbasi, I. N., Wu, F., Shi, Z., Sundus, J., Badry, A., Yuan, X., Zhao, B., Pan, J., Mi, X., et al. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105747 · Cited by 23
Metabolism in Immune Cell Differentiation and Function
Chapman, N. M., Shrestha, S., & Chi, H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-94-024-1170-6_1 · Cited by 22
Li, L., Nakano, D., Zhang, A., Kittikulsuth, W., Morisawa, N., Ohsaki, H., Suzuki, N., Yamamoto, M. P., & Nishiyama, A. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.09.004 · Cited by 20
Reduction of ARNT in myeloid cells causes immune suppression and delayed wound healing
Scott, C., Bonner, J. G., Min, D., Boughton, P. C., Stokes, R., Cha, K. M., Walters, S. N., Maslowski, K. M., Sierro, F., Grey, S. T., et al. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00306.2013 · Cited by 19
A humanized bone microenvironment uncovers HIF2 alpha as a latent marker for osteosarcoma
Wagner, F., Holzapfel, B. M., Martine, L. C., McGovern, J., Lahr, C. A., Boxberg, M., Prodinger, P. M., Grässel, S., Loessner, D., & Hutmacher, D. W. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.02.051 · Cited by 19
Qiu, S., Liu, T., Piao, C., Wang, Y., Wang, K., Zhou, Y., Cai, L., Zheng, S., Lan, F., & Du, J. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13978 · Cited by 19
Is nuclear sirtuin SIRT6 a master regulator of immune function?
Pillai, V. B., & Gupta, M. P. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00483.2020 · Cited by 18
Prostaglandin E2 in neuroblastoma: Targeting synthesis or signaling?
Hou, R., Yu, Y., & Jiang, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113966 · Cited by 18
Mendoza‐Reinoso, V., Schnepp, P. M., Baek, D. Y., Rubin, J. R., Schipani, E., Keller, E. T., McCauley, L. K., & Roca, H. (2022) · Cells · doi:10.3390/cells11233712 · Cited by 20
Vekariya, U. M., Rawat, K., Saxena, R., & Tripathi, R. K. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.10.010 · Cited by 21
Immunosurveillance of cancer cell stress
Lorenzo‐Herrero, S., Sordo‐Bahamonde, C., Gonzalez, S. R., & López‐Soto, A. (2019) · Cell Stress · doi:10.15698/cst2019.09.198 · Cited by 18
Zhang, P., Liu, G., Hu, J., Chen, S., Wang, B., Peng, P., Yu, X., & Guo, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.824586 · Cited by 18
Gojković, M., Cunha, P. P., Darmasaputra, G., Barbieri, L., Rundqvist, H., Veliça, P., & Johnson, R. S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.633586 · Cited by 17
Cui, L., Sun, F., Xu, Y., Li, M., Chen, L., Chen, C., Qian, J., Li, D., Du, M., & Wang, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021538 · Cited by 17
Hypoxia A Typical Target in Human Lung Cancer Therapy
Ullah, A., Shehzadi, S., Ullah, N., Nawaz, T., Iqbal, H., & Aziz, T. (2023) · Current Protein and Peptide Science · doi:10.2174/0113892037252820231114045234 · Cited by 17
Myeloid TGF-β signaling contributes to colitis-associated tumorigenesis in mice
Li, J., Liu, Y., Wang, B., Xu, Y., Ma, A., Zhang, F., Ge, C., Yang, Z., Li, J., & Liu, Y. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt172 · Cited by 17
Hypoxic Regulation of Neutrophils in Cancer
Triner, D. A., & Shah, Y. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174189 · Cited by 19
Sun, L., Guo, M. Z., Lv, Z., Shao, Y., & Li, C. (2020) · Aquaculture · doi:10.1016/j.aquaculture.2020.735393 · Cited by 17
Metadata
- Authors
- Imtiyaz, H. Z., Williams, E. P., Hickey, M. M., Patel, S. A., Durham, A. C., Yuan, L.-J., Hammond, R., Gimotty, P. A., Keith, B., & Simon, M. C.
- Affiliations
- Howard Hughes Medical Institute (US)
- Abramson Cancer Center (US)
- Corresponding author
- Simon, M. Celeste
- Venue
- Journal of Clinical Investigation
- Published
- 2010-08-02
- Volume
- 120
- Issue
- 8
- Pages
- 2699-2714
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2912179
- OpenAlex
- W2041418689
- Semantic Scholar
- f822a56ab9aa8dcad2e6f306df8394ee6666f231
- Cited by
- 461
- References
- 116
- Citations by year
- 2026: 17 · 2025: 23 · 2024: 22 · 2023: 26 · 2022: 38 · 2021: 45 · 2020: 33 · 2019: 27 · 2018: 29 · 2017: 18 · 2016: 32 · 2015: 23 · 2014: 36 · 2013: 29 · 2012: 32
- FWCI
- 12.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Cancer Research Institute
- National Institutes of Health
- Directorate for Biological Sciences
- U.S. Public Health Service (66310)
- Abramson Family Cancer Research Institute
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Macrophage Migration Inhibitory Factor
- Keywords
- HIF-2α, HIF-1α, tumor-associated macrophages, macrophage function, hypoxia, innate immunity, endotoxemia, lipopolysaccharide, inflammatory cytokines, chemokines, macrophage migration, M-CSF receptor, CXCR4, hepatocellular carcinoma, tumor inflammation, myeloid-specific knockout
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Acute Disease, Animals, Cell Movement, Disease Models, Animal, Female, Immunity, Innate, Inflammation, Lipopolysaccharides, Macrophages, Mice, Inbred C57BL, Neoplasms, Nitric Oxide, Cytokines, Endotoxemia, Receptors, CXCR4, Mice, Basic Helix-Loop-Helix Transcription Factors, Basic Helix-Loop-Helix Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
